These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
183 related articles for article (PubMed ID: 25230694)
21. Expression and prognostic significance of a comprehensive epithelial-mesenchymal transition gene set in renal cell carcinoma. Chen D; Gassenmaier M; Maruschke M; Riesenberg R; Pohla H; Stief CG; Zimmermann W; Buchner A J Urol; 2014 Feb; 191(2):479-86. PubMed ID: 24012533 [TBL] [Abstract][Full Text] [Related]
22. Overexpression of TNFAIP8 is associated with tumor aggressiveness and poor prognosis in patients with invasive ductal breast carcinoma. Xiao M; Xu Q; Lou C; Qin Y; Ning X; Liu T; Zhao X; Jia S; Huang Y Hum Pathol; 2017 Apr; 62():40-49. PubMed ID: 28087477 [TBL] [Abstract][Full Text] [Related]
23. Prognostic implications of Aquaporin 9 expression in clear cell renal cell carcinoma. Xu WH; Shi SN; Xu Y; Wang J; Wang HK; Cao DL; Shi GH; Qu YY; Zhang HL; Ye DW J Transl Med; 2019 Nov; 17(1):363. PubMed ID: 31703694 [TBL] [Abstract][Full Text] [Related]
24. Downregulation of FOXO3a promotes tumor metastasis and is associated with metastasis-free survival of patients with clear cell renal cell carcinoma. Ni D; Ma X; Li HZ; Gao Y; Li XT; Zhang Y; Ai Q; Zhang P; Song EL; Huang QB; Fan Y; Zhang X Clin Cancer Res; 2014 Apr; 20(7):1779-90. PubMed ID: 24486593 [TBL] [Abstract][Full Text] [Related]
25. miR-129-3p, as a diagnostic and prognostic biomarker for renal cell carcinoma, attenuates cell migration and invasion via downregulating multiple metastasis-related genes. Chen X; Ruan A; Wang X; Han W; Wang R; Lou N; Ruan H; Qiu B; Yang H; Zhang X J Cancer Res Clin Oncol; 2014 Aug; 140(8):1295-304. PubMed ID: 24802708 [TBL] [Abstract][Full Text] [Related]
26. Critical Roles for PU.1, GATA1, and GATA2 in the expression of human FcεRI on mast cells: PU.1 and GATA1 transactivate FCER1A, and GATA2 transactivates FCER1A and MS4A2. Inage E; Kasakura K; Yashiro T; Suzuki R; Baba Y; Nakano N; Hara M; Tanabe A; Oboki K; Matsumoto K; Saito H; Niyonsaba F; Ohtsuka Y; Ogawa H; Okumura K; Shimizu T; Nishiyama C J Immunol; 2014 Apr; 192(8):3936-46. PubMed ID: 24639354 [TBL] [Abstract][Full Text] [Related]
27. Decreased expression of NPRL2 in renal cancer cells is associated with unfavourable pathological, proliferation and apoptotic features. Tang Y; Jiang L; Tang W Pathol Oncol Res; 2014 Oct; 20(4):829-37. PubMed ID: 24789683 [TBL] [Abstract][Full Text] [Related]
28. Reduced stratifin expression can serve as an independent prognostic factor for poor survival in patients with esophageal squamous cell carcinoma. Ren HZ; Pan GQ; Wang JS; Wen JF; Wang KS; Luo GQ; Shan XZ Dig Dis Sci; 2010 Sep; 55(9):2552-60. PubMed ID: 20108042 [TBL] [Abstract][Full Text] [Related]
29. Hsa_circ_0085576 promotes clear cell renal cell carcinoma tumorigenesis and metastasis through the miR-498/YAP1 axis. Liu G; Zhou J; Piao Y; Zhao X; Zuo Y; Ji Z Aging (Albany NY); 2020 Jun; 12(12):11530-11549. PubMed ID: 32541093 [TBL] [Abstract][Full Text] [Related]
30. TGF-β-activated kinase-1: a potential prognostic marker for clear cell renal cell carcinoma. Wei C; Lai YQ; Li XX; Ye JX Asian Pac J Cancer Prev; 2013; 14(1):315-20. PubMed ID: 23534745 [TBL] [Abstract][Full Text] [Related]
31. RALY RNA binding protein-like reduced expression is associated with poor prognosis in clear cell renal cell carcinoma. Cui ZW; Xia Y; Ye YW; Jiang ZM; Wang YD; Wu JT; Sun L; Zhao J; Fa PP; Sun XJ; Gui YT; Cai ZM Asian Pac J Cancer Prev; 2012; 13(7):3403-8. PubMed ID: 22994768 [TBL] [Abstract][Full Text] [Related]
32. A regulatory network governing Gata1 and Gata2 gene transcription orchestrates erythroid lineage differentiation. Moriguchi T; Yamamoto M Int J Hematol; 2014 Nov; 100(5):417-24. PubMed ID: 24638828 [TBL] [Abstract][Full Text] [Related]
33. High expression of P53-induced Ring-h2 protein is associated with poor prognosis in clear cell renal cell carcinoma. Wu XR; Sha JJ; Liu DM; Chen YH; Yang GL; Zhang J; Chen YY; Bo JJ; Huang YR Eur J Surg Oncol; 2013 Jan; 39(1):100-6. PubMed ID: 23102595 [TBL] [Abstract][Full Text] [Related]
34. High expression of long non-coding RNA SPRY4-IT1 predicts poor prognosis of clear cell renal cell carcinoma. Zhang HM; Yang FQ; Yan Y; Che JP; Zheng JH Int J Clin Exp Pathol; 2014; 7(9):5801-9. PubMed ID: 25337221 [TBL] [Abstract][Full Text] [Related]
35. Decreased expression of dual-specificity phosphatase 9 is associated with poor prognosis in clear cell renal cell carcinoma. Wu S; Wang Y; Sun L; Zhang Z; Jiang Z; Qin Z; Han H; Liu Z; Li X; Tang A; Gui Y; Cai Z; Zhou F BMC Cancer; 2011 Sep; 11():413. PubMed ID: 21943117 [TBL] [Abstract][Full Text] [Related]
36. GATA5 CpG island hypermethylation is an independent predictor for poor clinical outcome in renal cell carcinoma. Peters I; Gebauer K; Dubrowinskaja N; Atschekzei F; Kramer MW; Hennenlotter J; Tezval H; Abbas M; Scherer R; Merseburger AS; Stenzl A; Kuczyk MA; Serth J Oncol Rep; 2014 Apr; 31(4):1523-30. PubMed ID: 24549248 [TBL] [Abstract][Full Text] [Related]
37. FSIP2 can serve as a predictive biomarker for Clear Cell Renal Cell Carcinoma prognosis. Zhang Y; Zhu X; Qiao X; Sun L; Tian Y; Yang Y; Zhao Y; Liu C Int J Med Sci; 2020; 17(17):2819-2825. PubMed ID: 33162809 [No Abstract] [Full Text] [Related]
38. NDUFA4L2 expression predicts poor prognosis in clear cell renal cell carcinoma patients. Liu L; Lan G; Peng L; Xie X; Peng F; Yu S; Wang Y; Tang X Ren Fail; 2016 Sep; 38(8):1199-205. PubMed ID: 27453328 [TBL] [Abstract][Full Text] [Related]
39. hZIP1 that is down-regulated in clear cell renal cell carcinoma is negatively associated with the malignant potential of the tumor. Dong X; Kong C; Zhang Z; Liu X; Zhan B; Chen Z; Shi D Urol Oncol; 2014 Aug; 32(6):885-92. PubMed ID: 24878177 [TBL] [Abstract][Full Text] [Related]
40. Up-regulation of SR-BI promotes progression and serves as a prognostic biomarker in clear cell renal cell carcinoma. Xu GH; Lou N; Shi HC; Xu YC; Ruan HL; Xiao W; Liu L; Li X; Xiao HB; Qiu B; Bao L; Yuan CF; Zhou YL; Hu WJ; Chen K; Yang HM; Zhang XP BMC Cancer; 2018 Jan; 18(1):88. PubMed ID: 29357836 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]